Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endostatin is a cleavage product of
collagen XVIII
that inhibits tumor angiogenesis and growth. Interferon alpha2a blocks tumor angiogenesis and causes regression of hemangiomas, but has no effect on choroidal neovascularization (CNV). Therefore, inhibitors of tumor angiogenesis do not necessarily inhibit ocular neovascularization. In this study, we used an intravenous injection of adenoviral vectors containing a sig-mEndo transgene consisting of murine immunoglobulin kappa-chain leader sequence coupled to sequence coding for murine
endostatin
to investigate the effect of high serum levels of
endostatin
on CNV in mice. Mice injected with a construct in which sig-mEndo expression was driven by the
Rous sarcoma
virus promoter had moderately high serum levels of
endostatin
and significantly smaller CNV lesions at sites of laser-induced rupture of Bruch's membrane than mice injected with null vector. Mice injected with a construct in which sig-mEndo was driven by the simian cytomegalovirus promoter had approximately 10-fold higher
endostatin
serum levels and had nearly complete prevention of CNV. There was a strong inverse correlation between
endostatin
serum level and area of CNV. This study provides proof of principle that gene therapy to increase levels of
endostatin
can prevent the development of CNV and may provide a new treatment for the leading cause of severe loss of vision in patients with age-related macular degeneration.
...
PMID:Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. 1143 78